Cédric Schneider
Claude Bernard University Lyon 1
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Cédric Schneider.
Journal of Medicinal Chemistry | 2009
Florence Popowycz; Guy Fournet; Cédric Schneider; Karima Bettayeb; Yoan Ferandin; Cyrile Lamigeon; Oscar M. Tirado; Silvia Mateo-Lozano; Vicente Notario; Pierre Colas; Philippe Bernard; Laurent Meijer; Benoı̂t Joseph
Pharmacological inhibitors of cyclin-dependent kinases (CDKs) have a wide therapeutic potential. Among the CDK inhibitors currently under clinical trials, the 2,6,9-trisubstituted purine (R)-roscovitine displays rather high selectivity, low toxicity, and promising antitumor activity. In an effort to improve this structure, we synthesized several bioisosteres of roscovitine. Surprisingly, one of them, pyrazolo[1,5-a]-1,3,5-triazine 7a (N-&-N1, GP0210), displayed significantly higher potency, compared to (R)-roscovitine and imidazo[2,1-f]-1,2,4-triazine 13 (N-&-N2, GP0212), at inhibiting various CDKs and at inducing cell death in a wide variety of human tumor cell lines. This approach may thus provide second generation analogues with enhanced biomedical potential.
Bioorganic & Medicinal Chemistry | 2009
Florence Popowycz; Cédric Schneider; Salvatore DeBonis; Dimitrios A. Skoufias; Frank Kozielski; Carlos M. Galmarini; Benoît Joseph
Pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives 1a-c were prepared from 4-(N-methyl-N-phenylamino)-2-methylsulfanylpyrazolo[1,5-a]-1,3,5-triazine 2. Their cytotoxic activity, inhibition of tubulin polymerization, and cell cycle effects were evaluated. Compounds 1a and 1c are potent tubulin inhibitors and displayed specific antiproliferative activity in colorectal cancer cell lines at micromolar concentrations.
Journal of Organic Chemistry | 2015
Jean-Baptiste E. Y. Rouchet; Cédric Schneider; Corinne Fruit; Christophe Hoarau
A straightforward method for direct decarboxylative arylation of 1- and 3-carboxy isoquinaldic acid N-oxides with aryl iodides is reported. The reaction proceeded selectively at the carboxy function site to exclusively give the corresponding C-1 or C-3 arylated product. This methodology tolerates various aryl iodides substituted by electronically different groups. Combined with subsequent Reissert-Henze chlorination and SNAr amination, the decarboxylative arylation provides an efficient access to 1,3-functionalized isoquinoline-based antitumor agent.
Chemcatchem | 2016
Laure Théveau; Cédric Schneider; Corinne Fruit; Christophe Hoarau
Transition metal‐catalyzed direct C−H bond functionalization of heterocycles with halo(het)arenes has received considerable attention as synthetic alternative to standard cross‐coupling reactions regarding step‐ and atom‐economy in the preparation of heteroarylmetals intermediates and better chemo‐selectivity towards standard organic functions such as aldehyde, ketone, ester, cyanide, and amide. An additional major and poorly highlighted interest of such methodology is its unparalleled ability to open the chemical space of functionalization of heterocycles towards challenging unprecedented sites. This Review gives an overview of the advances in challenging orthogonal direct C−H arylation of heterocycles related to the wide variety of catalytic C−H bond metalation processes, most of them evaluated by DFT calculations.
Organic Letters | 2018
Jonathan Hédouin; Cédric Schneider; Isabelle Gillaizeau; Christophe Hoarau
Palladium-catalyzed intramolecular carbopalladation onto allenamides completed by direct C-H allylation of heterocycles is studied. The domino construction/heteroarylation of isoquinolone process is first achieved. A general three-step one-pot strategy, involving in situ generation of allenamide, π-allyl-Pd complex generation, and interception with heteroarenes, has been subsequently set up. This methodology has been extended to the construction/heteroarylation of indoles, dihydroquinolines, isoquinolin(on)es, and medium-sized nitrogen heterocycles, which are known to be key challenging structural motifs with pharmaceutical significance.
Angewandte Chemie | 2013
Cédric Schneider; Daniela Masi; Samuel Couve-Bonnaire; Xavier Pannecoucke; Christophe Hoarau
European Journal of Organic Chemistry | 2010
Cédric Schneider; David Goyard; David Gueyrard; Benoît Joseph; Peter G. Goekjian
Tetrahedron | 2009
Cédric Schneider; David Gueyrard; Benoît Joseph; Peter G. Goekjian
ACS Catalysis | 2017
Jean-Baptiste E. Y. Rouchet; Mahmoud Hachem; Cédric Schneider; Christophe Hoarau
Synlett | 2007
Cédric Schneider; David Gueyrard; Florence Popowycz; Benoît Joseph; Peter G. Goekjian